MedPath

新疆银朵兰药业股份有限公司

Ownership
-
Established
2001-06-06
Employees
-
Market Cap
-
Website
http://xjydlyy.com/index1.asp

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

114

NMPA:114

Drug Approvals

复方比那甫西颗粒

Approval Number
国药准字Z20250003
Approval Date
Feb 26, 2025
NMPA

尿通卡克乃其片

Approval Number
国药准字Z20083004
Approval Date
Sep 14, 2023
NMPA

Oral Five Vitamins and Glucose

Product Name
口服五维葡萄糖
Approval Number
国药准字H65020196
Approval Date
Dec 29, 2020
NMPA

维C银翘片

Approval Number
国药准字Z20027856
Approval Date
Dec 20, 2020
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H65020200
Approval Date
Dec 17, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H65020162
Approval Date
Dec 7, 2020
NMPA

Pyritinol Hydrochloride Tablets

Product Name
盐酸吡硫醇片
Approval Number
国药准字H65020111
Approval Date
Nov 27, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H65020009
Approval Date
Nov 26, 2020
NMPA

温肾苏拉甫片

Approval Number
国药准字Z20064293
Approval Date
Nov 24, 2020
NMPA

复方丹参片

Approval Number
国药准字Z65020022
Approval Date
Nov 24, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.